WWB insider filings
WINDWARD BIO GROUP AG — 22 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-18. Screen WWB transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 22 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 3 filings by 4 insiders — 4,102,942 shares, $69,750,014 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 34.
- Largest priced transaction: purchase of 1,176,471 shares @ $17.00 ($20,000,007) by Bonita David P, filed 2026-11-18.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Stampacchia Otello — Director | 3 | 2 legs · 1,750,000 sh · $29,750,000 | — | 9 |
| Bonita David P — Director, 10% owner | 3 | 1 leg · 1,176,471 sh · $20,000,007 | — | 8 |
| ORBIMED ADVISORS LLC — Director, 10% owner & OrbiMed Capital GP IX LLC — Director, 10% owner | 2 | 1 leg · 1,176,471 sh · $20,000,007 | — | 7 |
| Applebaum Scott — Chief Legal & Corp Dev Officer | 2 | — | — | 2 |
| Harris Kevin Andrew — Chief Operating Officer | 2 | — | — | 2 |
| Kapadia Sandip — Director | 2 | — | — | 2 |
| D'Augusta Claudia — Chief Financial Officer | 2 | — | — | 1 |
| Khwaja Omar — Chief Medical Officer | 2 | — | — | 1 |
| Mufti Iqbal Rasool — Director | 2 | — | — | 1 |
| Santarelli Luca — Chief Executive Officer, Director | 2 | — | — | 1 |
Recent insider filings — WINDWARD BIO GROUP AG
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-18 | 4 | Bonita David P — Director, 10% owner | Purchase (P): 1,176,471 @ $17 · Conversion (C): 3,561,936 · Conversion (C): 1,611,008 · Option exercise (M): 216,668 @ $0.02 · Tax withholding (F): 232 @ $17 · Conversion (C): 3,561,936 (derivative) @ $0 · +2 more | EDGAR |
| 2026-11-18 | 4 | ORBIMED ADVISORS LLC — Director, 10% owner OrbiMed Capital GP IX LLC — Director, 10% owner | Purchase (P): 1,176,471 @ $17 · Conversion (C): 3,561,936 · Conversion (C): 1,611,008 · Option exercise (M): 216,668 @ $0.02 · Tax withholding (F): 232 @ $17 · Conversion (C): 3,561,936 (derivative) @ $0 · +2 more | EDGAR |
| 2026-11-18 | 4 | Stampacchia Otello — Director | Purchase (P): 875,000 @ $17 · Purchase (P): 875,000 @ $17 · Conversion (C): 1,262,628 · Conversion (C): 1,262,626 · Conversion (C): 531,632 · Conversion (C): 531,634 · +4 more | EDGAR |
| 2026-11-16 | 4 | Applebaum Scott — Chief Legal & Corp Dev Officer | Grant/award (A): 33,206 @ $0 · Grant/award (A): 180,160 (derivative) @ $0 | EDGAR |
| 2026-11-16 | 4 | Harris Kevin Andrew — Chief Operating Officer | Grant/award (A): 33,206 @ $0 · Grant/award (A): 180,160 (derivative) @ $0 | EDGAR |
| 2026-11-16 | 4 | Kapadia Sandip — Director | Grant/award (A): 100,000 @ $0 · Grant/award (A): 22,675 (derivative) @ $0 | EDGAR |
| 2026-11-16 | 4 | Santarelli Luca — Chief Executive Officer, Director | Grant/award (A): 815,755 (derivative) @ $0 | EDGAR |
| 2026-11-16 | 4 | Khwaja Omar — Chief Medical Officer | Grant/award (A): 219,030 (derivative) @ $0 | EDGAR |
| 2026-11-16 | 4 | D'Augusta Claudia — Chief Financial Officer | Grant/award (A): 180,160 (derivative) @ $0 | EDGAR |
| 2026-11-16 | 4 | Bonita David P — Director | Grant/award (A): 22,675 (derivative) @ $0 | EDGAR |
| 2026-11-16 | 4 | Stampacchia Otello — Director | Grant/award (A): 22,675 (derivative) @ $0 | EDGAR |
| 2026-11-16 | 4 | Mufti Iqbal Rasool — Director | Grant/award (A): 22,675 (derivative) @ $0 | EDGAR |
| 2026-11-12 | 3 | ORBIMED ADVISORS LLC — Director, 10% owner OrbiMed Capital GP IX LLC — Director, 10% owner | Holdings only — no transactions reported | EDGAR |
| 2026-11-12 | 3 | Mufti Iqbal Rasool — Director | Holdings only — no transactions reported | EDGAR |
| 2026-11-12 | 3 | Santarelli Luca — Chief Executive Officer, Director | Holdings only — no transactions reported | EDGAR |
| 2026-11-12 | 3 | Bonita David P — Director | Holdings only — no transactions reported | EDGAR |
| 2026-11-12 | 3 | Stampacchia Otello — Director | Holdings only — no transactions reported | EDGAR |
| 2026-11-12 | 3 | Khwaja Omar — Chief Medical Officer | Holdings only — no transactions reported | EDGAR |
| 2026-11-12 | 3 | Harris Kevin Andrew — Chief Operating Officer | Holdings only — no transactions reported | EDGAR |
| 2026-11-12 | 3 | D'Augusta Claudia — Chief Financial Officer | Holdings only — no transactions reported | EDGAR |
| 2026-11-12 | 3 | Kapadia Sandip — Director | Holdings only — no transactions reported | EDGAR |
| 2026-11-12 | 3 | Applebaum Scott — Chief Legal & Corp Dev Officer | Holdings only — no transactions reported | EDGAR |
Registration filings — WINDWARD BIO GROUP AG
Securities Act registration lifecycles tracked for this issuer (live-forward since 2026-08-01), threaded by SEC file number.
- SEC file 333-299608 (F-1) — latest: Final prospectus (424B4), filed 2026-11-16
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=WWB returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs